Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3

Blood

Volumn 97, Issue 3, 2001, Pages 720-728

  Holyoake, Tessa L ^a   Jiang, Xiaoyan ^b   Jorgensen, Heather G ^b   Graham, Susan ^b   Alcorn, Michael J ^b   Laird, Chris ^b   Eaves, Allen C ^b   Eaves, Connie J ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CD34 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 3; KI 67 ANTIGEN; PROTEIN TYROSINE PHOSPHATASE;

ANTIGEN EXPRESSION; ARTICLE; CELL CLONE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKEMIA CELL; PRIORITY JOURNAL;

EID: 0035254540     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.3.720     Document Type: Article

References (53)

1. The use of cell markers in the study of human hematopoietic neoplasia
2. Cell culture studies in CML
3. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
4. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene
5. The molecular genetics of Philadelphia chromosome-positive leukemias
6. Tyresine kinase activity and transformation potency of bcr-abl oncegene products
7. bcr/abl gene of the Philadelphia chromosome
8. Acute leukemia in bcr/abl transgenic mice
9. Clonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice
10. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia
11. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematepoietic cell lines transformed by Bcr-Abl
12. Constitutive activation of JAKS and STATS in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients
13. Activation of hematopoietic growth factor signal transduction pathways by the human oncegene BCR/ABL
14. Discordant maturation as the primary biological defect in chronic myelogenous leukemia
15. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia
16. BCR-ABL accelerates C2-ceramide-induced apoptosis
17. Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia
18. + cells from patients with chrenic myeloid leukemia
19. Differences between normal and CML stem cells: Potential targets for clinical exploitation
20. + cells
21. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level
22. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia
23. Cytokine manipulation of primitive human hematopoietic cell self-renewal
24. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia
25. Purification of hematopoietic stem cells for further biological study
26. Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia
27. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro
28. + cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow
29. Expression of CD34 on human B cell precursors
30. Flow cytometric estimation of DNA and RNA content in intact cells stained with Hoechst 33342 and Pyronin Y
31. - cell production in vitro
32. + subpopulations of human bone marrow cells
33. + cells from patients with cloronic myeloid leukemia
34. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium
35. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice
36. BCR-ABL oncogene renders myeloid cell line factor independent: Potential autocrine mechanism in chronic myeloid leukemia
37. Expression of the chronic myelogenous leukemia-associated p210bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line
38. Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism
39. The BCR-ABL oncogene requires both kinase activity and src-homology 2 domain to induce cytokine secretion
40. BCR-ABL gene rearrangement and expression of primitive hematopoietic pregenitors in chronic myeloid leukemia
41. Subcellular localization of BCR, ABL and BCR-ABL proteins in normal and leukemic cells and correlation of expression with myeloid differentiation
42. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1α, an inhibitor of primitive normal hematopoietic cells
43. MCP-1, not MIP-1α is the endogenous chemokine that cooperates with TGF-β to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures
44. Transforming growth factor-β selectively inhibits normal and leukemic human bone marrow cell growth in vitro
45. Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-β on normal and leukemic human hematopoietic progenitor cells
46. Differentiation stage-specific regulation of primitive human hematopeietic progenitor cycling by exogenous and endogenous inhibitors in an in vivo model
47. Effects of a selective inhibitor of the ABL tyrosine kinase on the growth of BCR-ABL positive cells
48. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase
49. + cells
50. The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: An in vivo model of chronic myelogenous leukemia biology
51. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow
52. BCR-ABL efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: A novel model for chronic myelogenous leukemia
53. The p190, p210, and p230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity